Sofiva Genomics Co.,Ltd.
Sofiva Genomics Co.,Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M… Read more
Market Cap & Net Worth: Sofiva Genomics Co.,Ltd. (6615)
Sofiva Genomics Co.,Ltd. (TWO:6615) has a market capitalization of $10.13K (NT$335.02K) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #45080 globally and #1999 in its home market, demonstrating a -0.43% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sofiva Genomics Co.,Ltd.'s stock price NT$34.40 by its total outstanding shares 9739 (9.74K).
Sofiva Genomics Co.,Ltd. Market Cap History: 2025 to 2026
Sofiva Genomics Co.,Ltd.'s market capitalization history from 2025 to 2026. Data shows growth from $8.87K to $10.13K (0.00% CAGR).
Sofiva Genomics Co.,Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sofiva Genomics Co.,Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6615 by Market Capitalization
Companies near Sofiva Genomics Co.,Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Sofiva Genomics Co.,Ltd. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Sofiva Genomics Co.,Ltd. Historical Marketcap From 2025 to 2026
Between 2025 and today, Sofiva Genomics Co.,Ltd.'s market cap moved from $8.87K to $ 10.13K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$10.13K | +14.10% |
| 2025 | NT$8.87K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sofiva Genomics Co.,Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.13K USD |
| MoneyControl | $10.13K USD |
| MarketWatch | $10.13K USD |
| marketcap.company | $10.13K USD |
| Reuters | $10.13K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.